Association of miR-155 and MIR155HG polymorphisms with cancer risk: A meta-analysis
文献类型：期刊论文
| 作者 | Zou, Zhishan1; Lu, Hui1; Zhang, Wenliang2,3; Li, Yiming1; He, Yi1; Lin, Huancai1; Zhao, Wei1; Yu, Dongsheng1; Zeng, Binghui1 |
| 刊名 | JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
 |
| 出版日期 | 2021-11-01 |
| 卷号 | 17期号:5页码:1209-+ |
| ISSN号 | 0973-1482 |
| 关键词 | Cancer meta-analysis miR-155 non-small-cell lung cancer polymorphism |
| DOI | 10.4103/jcrt.jcrt_913_21 |
| 英文摘要 | Background: Analysis of emerging data shows that miRNAs, including miR-155, play important roles in tumorigenesis. Several studies have indicated that miR-155 and MIR155HG polymorphisms may be related to cancer risk, but the association was controversial. Therefore, we conducted this first-reported comprehensive meta-analysis of the association of miR-155 and MIR155HG polymorphisms with cancer risk. Materials and Methods: We searched several databases, including PubMed, Embase, and Web of Science, to identify the eligible studies reporting the association of miR-155 and MIR155HG polymorphisms with cancer risk. We calculated the pooled odds ratios (ORs) and 95% confidence intervals (CIs) to analyze the association. Stata software (version 16.0) was used to analyze the data we collected. Results: After being carefully and strictly screened, eight articles reporting on six common single-nucleotide polymorphisms consisting of 6184 cases and 6896 controls were included in this meta-analysis. The six polymorphisms included were rs767649 (T>A), rs928883 (A>G), rs2829803 (G>A), rs1893650 (T>C), rs4143370 (G>C), and rs12482371 (T>C). Our results showed that, in the overall analysis, heterozygotes increased cancer risk, with a marginal P value, compared with wild-type (OR = 1.06, 95% CI = 1.00-1.12, P = 0.062). Subsequent analyses showed that only rs767649 was associated with an increased risk of non-small-cell lung cancer (NSCLC) in an allele model (T vs. A: OR = 1.15, 95% CI = 1.04-1.26, P = 0.007), a homozygote model (TT vs. AA: OR = 1.31, 95% CI = 1.06-1.60, P = 0.011), and a recessive model (TT vs. AT + AA: OR = 1.30, 95% CI = 1.08-1.55, P = 0.005). Conclusion: The present meta-analysis indicates that the rs767649 polymorphism might be a potential factor for NSCLC risk; however, more studies should be conducted to confirm these findings. |
| 资助项目 | Fundamental Research Funds of the Central Universities, Sun Yat-Sen University[19ykpy86] ; China Postdoctoral Science Foundation[2020M673023] ; National Natural Science Foundation of China[81873711] ; National Natural Science Foundation of China[82073378] |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | WOLTERS KLUWER MEDKNOW PUBLICATIONS |
| WOS记录号 | WOS:000754557100009 |
| 源URL | [http://119.78.100.204/handle/2XEOYT63/18988]  |
| 专题 | 中国科学院计算技术研究所期刊论文_英文 |
| 通讯作者 | Yu, Dongsheng; Zeng, Binghui |
| 作者单位 | 1.Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Peoples R China 2.Univ Hong Kong Shenzhen Hosp, Dept Pediat, Shenzhen, Peoples R China 3.Chinese Acad Sci, Ctr High Performance Comp, Joint Engn Res Ctr Hlth Big Data Intelligent Anal, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zou, Zhishan,Lu, Hui,Zhang, Wenliang,et al. Association of miR-155 and MIR155HG polymorphisms with cancer risk: A meta-analysis[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,2021,17(5):1209-+. |
| APA | Zou, Zhishan.,Lu, Hui.,Zhang, Wenliang.,Li, Yiming.,He, Yi.,...&Zeng, Binghui.(2021).Association of miR-155 and MIR155HG polymorphisms with cancer risk: A meta-analysis.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,17(5),1209-+. |
| MLA | Zou, Zhishan,et al."Association of miR-155 and MIR155HG polymorphisms with cancer risk: A meta-analysis".JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 17.5(2021):1209-+. |
入库方式： OAI收割
来源：计算技术研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。